BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8166148)

  • 1. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
    de Herder WW; Krenning EP; Malchoff CD; Hofland LJ; Reubi JC; Kwekkeboom DJ; Oei HY; Pols HA; Bruining HA; Nobels FR
    Am J Med; 1994 Apr; 96(4):305-12. PubMed ID: 8166148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for somatostatin and its analogs in Cushing's syndrome?
    de Herder WW; Lamberts SW
    Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
    Schteingart DE; Lloyd RV; Akil H; Chandler WF; Ibarra-Perez G; Rosen SG; Ogletree R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):770-5. PubMed ID: 3525603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
    Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide exerts different effects in vivo and in vitro in Cushing's disease.
    Stalla GK; Brockmeier SJ; Renner U; Newton C; Buchfelder M; Stalla J; Müller OA
    Eur J Endocrinol; 1994 Feb; 130(2):125-31. PubMed ID: 8130885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's syndrome due to ectopic production of corticotropin-releasing hormone in an infant with ganglioneuroblastoma.
    Zangeneh F; Young WF; Lloyd RV; Chiang M; Kurczynski E; Zangeneh F
    Endocr Pract; 2003; 9(5):394-9. PubMed ID: 14583423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it.
    Karageorgiadis AS; Papadakis GZ; Biro J; Keil MF; Lyssikatos C; Quezado MM; Merino M; Schrump DS; Kebebew E; Patronas NJ; Hunter MK; Alwazeer MR; Karaviti LP; Balazs AE; Lodish MB; Stratakis CA
    J Clin Endocrinol Metab; 2015 Jan; 100(1):141-8. PubMed ID: 25291050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
    de Bruin C; Hofland LJ; Nieman LK; van Koetsveld PM; Waaijers AM; Sprij-Mooij DM; van Essen M; Lamberts SW; de Herder WW; Feelders RA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):455-62. PubMed ID: 22090282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.
    Lamberts SW; Hofland LJ; de Herder WW; Kwekkeboom DJ; Reubi JC; Krenning EP
    Front Neuroendocrinol; 1993 Jan; 14(1):27-55. PubMed ID: 8097480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
    Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.
    Schalin-Jäntti C; Asa SL; Arola J; Sane T
    Endocr Pathol; 2013 Mar; 24(1):25-9. PubMed ID: 23233312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
    Suda T
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma.
    Puchner MJ; Lüdecke DK; Valdueza JM; Saeger W; Willig RP; Stalla GK; Odink RJ
    Neurosurgery; 1993 Nov; 33(5):920-4; discussion 924-5. PubMed ID: 8264895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
    Malchoff CD; Orth DN; Abboud C; Carney JA; Pairolero PC; Carey RM
    Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.